John Lauriello MD
Professor and Chairman, Department of Psychiatry and Human Behavior, Sidney Kimmel Medical College-Jefferson Health
Join to view full profile
833 Chestnut StSte 210Philadelphia, PA 19107
Phone+1 215-955-6913
Dr. Lauriello is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Psychiatry, 1986 - 1990
Lewis Katz School of Medicine at Temple UniversityClass of 1986
Certifications & Licensure
PA State Medical License 2019 - 2026
CA State Medical License 1990 - 2025
MO State Medical License 2009 - 2020
NM State Medical License 1994 - 2010
American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification PowerChart (CQM), Cerner Corporation, 2013, 2015-2017
- CMS Meaningful Use Stage 1 Certification HealthSentry, Cerner Corporation, 2013, 2015-2017
- CMS Meaningful Use Stage 1 Certification PathNet, Cerner Corporation, 2013, 2015-2017
Clinical Trials
- Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone Start of enrollment: 2010 Jul 01
Publications & Presentations
PubMed
- Treatment Patterns and Healthcare Resource Utilization Following Initiation of Aripiprazole Lauroxil Using a 1-Day Initiation Regimen in Patients with Schizophrenia.John Lauriello, Michael J Doane, James A McGrory, Alejandro G Hughes, Lauren N Strand
Advances in Therapy. 2025-09-01 - 55 citationsVariability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis.Kate Merritt, Robert A McCutcheon, André Aleman, Sarah Ashley, Katherine Beck
Molecular Psychiatry. 2023-05-01 - 9 citationsLongitudinal study of inflammation and relapse in schizophrenia.Brian J Miller, Henrique Lemos, Nina R Schooler, Donald C Goff, Alexander Kopelowicz
Schizophrenia Research. 2023-02-01
Other
- Pharmacotherapy for schizophrenia: Long-acting injectable antipsychotic drugsLauriello J, Campbell AR
http://www.uptodate.com/contents/pharmacotherapy-for-schizophrenia-long-acting-injectable-antipsycho
UpToDate, Wolters Kluwer Health - 2013-02-14
Press Mentions
How to Recognize Tardive DyskinesiaOctober 3rd, 2024- Assessing Tardive Dyskinesia RiskSeptember 5th, 2024
- Aripiprazole Lauroxil Appears to Improve Schizophrenia Symptoms Safely, SignificantlyAugust 26th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
